News

Anthem Biosciences Ltd, a CRDMO founded in 2006, offers end-to-end drug discovery-to-manufacturing services and specialises ...
Following the close of the subscription of initial public offering (IPO) of Anthem Biosciences Limited, all eyes of the ...
Anthem Biosciences' IPO ended on 16 July, with the issue booked over 60 times. Strong demand from qualified institutional ...
The initial public offer of Anthem Biosciences received bids for 2,81,44,34,740 shares as against 4,40,70,682 shares on offer, according to stock exchange data at 17:30 IST on Wednesday (16 July 2025) ...
Today is the last day for investors to subscribe for the Anthem Biosciences IPO, which so far has gathered a lot of attention ...
The initial public offering of Anthem Biosciences Ltd. has been subscribed to nearly eight times the offer on its third and ...
Anthem Biosciences IPO closes today; check GMP, latest subscription stats, and key dates -act now before bidding ends!
Indian drugmaker Anthem Biosciences' ANTH.NS $395 million IPO was fully subscribed on the second day of bidding on Tuesday, ...
Anthem Biosciences IPO GMP surged on Wednesday as the Rs 3,395-crore initial share saw robust subscription on the concluding ...
Anthem Biosciences Ltd's IPO was subscribed 63.86 times by closing day, driven by institutional buyers. The Rs 3,395-crore ...
Anthem Biosciences has launched its IPO on July 14, closing on July 16. The ₹3,395 crore offer is entirely for sale by ...
Anthem Biosciences is selling its shares in the price band of Rs 540-570, applied for a minimum of 26 shares and its ...